Recent News

• XSENSIO ANNOUNCES KNOW-HOW AND STOCK PURCHASE AGREEMENT WITH MAYO CLINIC
• XSENSIO INVITED ON PODCAST “IMPULSE – MEETING HEALTHCARE PIONEERS”
• XSENSIO VOTED BEST PITCH BY DEEPTECH INVESTOR COMMUNITY AT INPHO VENTURE SUMMIT
• XSENSIO ON PODCAST “DART FOUNDER SERIES”
• NICOLA BRAMWELL JOINS THE BOARD OF DIRECTORS OF XSENSIO AS INDEPENDENT MEMBER
• XSENSIO WORKS WITH PHARMA COMPANY UCB TO INNOVATION ALONG THE PATIENT JOURNEY
• XSENSIO SELECTED BY THE MAYO CLINIC IN THE US TO JOIN COMPETITIVE ACCELERATOR PROGRAM
• XSENSIO RAISES CHF 4.2 MILLION IN A FIRST CLOSE
• XSENSIO FEATURED IN STARTUPTICKER.CH “SPORTS SCIENTISTS HAVE BEEN DREAMING OF THIS KIND OF CONTINUOUS DATA”
• XSENSIO MAKES 1st DEPLOYMENT AT MOTIONLAB ​